CFTR and cystic fibrosis: Although drugs that target the CFTR have recently been approved and show great promise, it is still not clear how CFTR modulators affect the infection and inflammation, and the research on novel anti-inflammatory agents has been obscured by the discovery of CFTR modulators, thereby inflammation represents “a sort of orphan target in CF” [15].